Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Alhenc-Gelas

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Gynecologie, Obstetrique & Fertilite|January 5, 2002
[The biological distribution of thrombosis in the year 2000]M Alhenc-Gelas
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 26, 2003
[Genetics of venous thromboembolism]M Alhenc-Gelas, M Aiach
Gynecologie, Obstetrique & Fertilite|August 30, 2002
[Analytical choices for biological tests in thrombotic pathology]M Aiach, M Alhenc-Gelas
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 1, 1995
A rapid screening method for the factor V Arg506-->Gln mutationS Gandrille, M Alhenc-Gelas, M Aiach
Journal of Thrombosis and Haemostasis : JTH|January 22, 2010
Influence of natural SERPINC1 mutations on ex vivo thrombin generationM Alhenc-Gelas, M Canonico, V Picard
Seminars in Vascular Medicine|June 17, 2004
Venous thromboembolic disease: risk factors and laboratory investigationM Alhenc-Gelas, M Aiach, P de Moerloose
Nouvelle Revue Francaise D'Hematologie|January 1, 1993
Contribution of platelet protein S (PS) to PS levels measured in plasmaM Alhenc-Gelas, M L Aubry, M Aiach
Thrombosis and Haemostasis|April 1, 1995
Evaluation of APC resistance in the plasma of patients with Q506 mutation of factor V (factor V Leiden) and treated by oral anticoagulantsY Cadroy, P Sié, M Alhenc-Gelas, et al.
Nephron|January 1, 1995
Pharmacokinetic study of the low-molecular-weight heparin fraxiparin in patients with nephrotic syndromeM Alhenc-Gelas, J Rossert, C Jacquot, et al.
Thrombosis and Haemostasis|February 11, 2000
Thirty-three novel mutations in the protein C gene. French INSERM network on molecular abnormalities responsible for protein C and protein SM Alhenc-Gelas, S Gandrille, M L Aubry, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Gynecologie, Obstetrique & Fertilite|January 5, 2002
[The biological distribution of thrombosis in the year 2000]M Alhenc-Gelas
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 26, 2003
[Genetics of venous thromboembolism]M Alhenc-Gelas, M Aiach
Gynecologie, Obstetrique & Fertilite|August 30, 2002
[Analytical choices for biological tests in thrombotic pathology]M Aiach, M Alhenc-Gelas
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 1, 1995
A rapid screening method for the factor V Arg506-->Gln mutationS Gandrille, M Alhenc-Gelas, M Aiach
Journal of Thrombosis and Haemostasis : JTH|January 22, 2010
Influence of natural SERPINC1 mutations on ex vivo thrombin generationM Alhenc-Gelas, M Canonico, V Picard
Seminars in Vascular Medicine|June 17, 2004
Venous thromboembolic disease: risk factors and laboratory investigationM Alhenc-Gelas, M Aiach, P de Moerloose
Nouvelle Revue Francaise D'Hematologie|January 1, 1993
Contribution of platelet protein S (PS) to PS levels measured in plasmaM Alhenc-Gelas, M L Aubry, M Aiach
Thrombosis and Haemostasis|April 1, 1995
Evaluation of APC resistance in the plasma of patients with Q506 mutation of factor V (factor V Leiden) and treated by oral anticoagulantsY Cadroy, P Sié, M Alhenc-Gelas, et al.
Nephron|January 1, 1995
Pharmacokinetic study of the low-molecular-weight heparin fraxiparin in patients with nephrotic syndromeM Alhenc-Gelas, J Rossert, C Jacquot, et al.
Thrombosis and Haemostasis|February 11, 2000
Thirty-three novel mutations in the protein C gene. French INSERM network on molecular abnormalities responsible for protein C and protein SM Alhenc-Gelas, S Gandrille, M L Aubry, et al.
Pageof 9